Protocol #14-003: A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate hydrochloride] in the Treatment of Excessive Sleepiness in Subject

Project: Research project

Project Details

StatusFinished
Effective start/end date6/16/156/16/18

Funding

  • INC Research, LLC (Protocol #14-003 // Protocol #14-003)
  • Jazz Pharmaceuticals, Inc. (Protocol #14-003 // Protocol #14-003)